ロード中...
Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond
The pharmacotherapy of inflammatory bowel diseases (Crohn’s disease and ulcerative colitis) has experienced significant progress with the advent of monoclonal antibodies (mABs). As therapeutic proteins, mABs display peculiar pharmacokinetic characteristics that differentiate them from chemical drugs...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7898166/ https://ncbi.nlm.nih.gov/pubmed/33628180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.610806 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|